T1	Temporal 0 12	Preoperative
T2	Measurement 13 23	Hemoglobin
T3	Value 24 39	<U+2266>11 g/dl
R1	Has_value Arg1:T2 Arg2:T3	
R2	Has_temporal Arg1:T2 Arg2:T1	
T4	Condition 52 61	infection
T5	Condition 65 88	intraarticular fracture
T6	Qualifier 96 109	affective hip
*	OR T5 T4
T7	Scope 52 88	infection or intraarticular fracture
R3	Has_qualifier Arg1:T7 Arg2:T6	
T8	Observation 41 48	History
R4	Has_temporal Arg1:T7 Arg2:T8	
T9	Condition 111 136	Renal function deficiency
T10	Measurement 138 141	GFR
T11	Value 142 159	<30 ml/min/1.73m2
R5	Has_value Arg1:T10 Arg2:T11	
T12	Scope 138 159	GFR <30 ml/min/1.73m2
R6	Subsumes Arg1:T9 Arg2:T12	
T13	Measurement 171 183	liver enzyme
T14	Value 162 170	Elevated
R7	Has_value Arg1:T13 Arg2:T14	
T15	Measurement 185 246	aspartate transaminase (AST)/ alanine transaminase(ALT) level
T16	Value 251 279	more than twice normal range
R8	Has_value Arg1:T15 Arg2:T16	
T17	Observation 283 290	history
T18	Condition 294 309	liver cirrhosis
T19	Condition 311 334	impaired liver function
T20	Value 335 343	elevated
T21	Measurement 344 365	total bilirubin level
R9	Has_value Arg1:T21 Arg2:T20	
T22	Condition 371 383	coagulopathy
T23	Multiplier 395 408	long-term use
T24	Drug 409 422	anticoagulant
R10	Has_multiplier Arg1:T24 Arg2:T23	
T25	Scope 395 422	long-term use anticoagulant
T26	Condition 436 456	deep vein thrombosis
T27	Condition 458 480	ischemic heart disease
T28	Condition 484 490	stroke
*	OR T27 T28 T26
T29	Condition 492 509	Contraindications
T30	Drug 513 528	tranexamic acid
T31	Drug 530 537	floseal
T32	Drug 542 553	rivaroxaban
*	OR T31 T32 T30
T33	Scope 513 553	tranexamic acid, floseal, or rivaroxaban
R11	Has_scope Arg1:T29 Arg2:T33	
T34	Condition 555 562	Allergy
T35	Drug 566 581	tranexamic acid
T36	Drug 583 590	floseal
T37	Drug 592 603	rivaroxaban
T38	Drug 612 622	excipients
*	OR T38 T37 T36 T35
T39	Scope 566 622	tranexamic acid, floseal, rivaroxaban, or the excipients
R12	Subsumes Arg1:T34 Arg2:T39	
T40	Condition 635 673	heparin-induced thrombocytopenia (HIT)
T41	Observation 624 631	History
R13	Has_temporal Arg1:T40 Arg2:T41	
T42	Condition 675 687	Coagulopathy
T43	Condition 691 708	bleeding tendency
T44	Condition 719 736	organ dysfunction
T45	Condition 746 755	cirrhosis
T46	Condition 757 780	bone marrow suppression
*	OR T45 T46
T47	Scope 746 780	cirrhosis, bone marrow suppression
R14	Subsumes Arg1:T44 Arg2:T47	
*	OR T43 T42
T48	Scope 675 708	Coagulopathy or bleeding tendency
R15	AND Arg1:T48 Arg2:T44	
T49	Qualifier 804 810	active
T50	Condition 811 828	bleeding disorder
T51	Condition 838 861	intracranial hemorrhage
T52	Condition 863 894	upper gastrointestinal bleeding
T53	Condition 896 905	hematuria
*	OR T52 T53 T51
T54	Scope 838 905	intracranial hemorrhage, upper gastrointestinal bleeding, hematuria
R16	Has_qualifier Arg1:T50 Arg2:T49	
R17	Subsumes Arg1:T50 Arg2:T54	
T55	Condition 928 937	allergies
T56	Drug 941 967	materials of bovine origin
R18	AND Arg1:T55 Arg2:T56	
